TransEnterix secures $55 million in Series B funding round - MarketLine Financial Deals

TransEnterix secures $55 million in Series B funding round

TransEnterix secures $55 million in Series B funding round - MarketLine Financial Deals
TransEnterix secures $55 million in Series B funding round
Published Oct 07, 2009
3 pages — Published Oct 07, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

TransEnterix, Inc., a US-based developer of invasive laparoscopic surgery platform, has secured $55 million in Series B funding round led by Aisling Capital.

  
Source:
Document ID
MA10172_091008
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "TransEnterix secures $55 million in Series B funding round" Oct 07, 2009. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TransEnterix-secures-55-million-in-Series-B-funding-round-2052-9765>
  
APA:
MarketLine Financial Deals. (2009). TransEnterix secures $55 million in Series B funding round Oct 07, 2009. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/TransEnterix-secures-55-million-in-Series-B-funding-round-2052-9765>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.